Harvard Bioscience, Inc.
HBIO
$0.762
-$0.0119-1.54%
| 09/30/2024 | 06/30/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -4.88% | -5.77% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -4.88% | -5.77% | |||
| Cost of Revenue | -6.82% | 1.43% | |||
| Gross Profit | -3.43% | -10.52% | |||
| SG&A Expenses | -4.71% | -6.62% | |||
| Depreciation & Amortization | 0.23% | -0.15% | |||
| Other Operating Expenses | -- | -115.22% | |||
| Total Operating Expenses | -4.46% | -7.54% | |||
| Operating Income | -1.32% | 26.59% | |||
| Income Before Tax | -36.92% | 26.85% | |||
| Income Tax Expenses | 188.10% | -268.10% | |||
| Earnings from Continuing Operations | -64.06% | 37.64% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -64.06% | 37.64% | |||
| EBIT | -1.32% | 26.59% | |||
| EBITDA | -6.25% | 125.70% | |||
| EPS Basic | -63.60% | 37.80% | |||
| Normalized Basic EPS | -48.92% | 35.76% | |||
| EPS Diluted | -57.29% | 36.36% | |||
| Normalized Diluted EPS | -48.92% | 35.76% | |||
| Average Basic Shares Outstanding | 0.29% | 0.19% | |||
| Average Diluted Shares Outstanding | 0.29% | 0.19% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||
